Zimmer Biomet Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on November 4, 2021, by Zimmer Biomet Holdings, Inc. (ZBH), a Delaware corporation. The filing serves to report the Company's financial results for the quarter ended September 30, 2021, via a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) and are not explicitly detailed in the body of this 8-K filing.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only indicates that results for the quarter ended September 30, 2021, have been issued.
Guidance, Outlook, and Risks
The filing does not include specific management commentary, guidance, outlook, risks, or contingencies within the text provided. The document states that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting its incorporation by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 4, 2021) for actual revenue, earnings, and cash flow figures.
- Verify specific year-over-year growth rates and margin changes in the attached press release.
- Check for updated forward-looking guidance or outlook statements in the press release.
- Confirm the status of outstanding debt instruments listed (1.414% Notes due 2022, 2.425% Notes due 2026, 1.164% Notes due 2027) in the full financial statements.